Measuring the Level of Participation and Autonomy among people with Type II diabetes, Rafsanjan, Iran (2016)

Vazirinejad, R; Rezaeian, M; Nazari, F; Hosseini , SM

doi:10.18869/acadpub.johe.5.4.235

Volume 5, Issue 4 (Autumn 2016) J Occup Health Epidemiol 2016, 5(4): 235-244 | Back to browse issues page

‎ 10.18869/acadpub.johe.5.4.235

‎ 20.1001.1.22518096.2016.5.4.4.4

Mendeley

Zotero

RefWorks

Vazirinejad R, Rezaeian M, Nazari F, Hosseini S. Measuring the Level of Participation and Autonomy among people with Type II diabetes, Rafsanjan, Iran (2016). J Occup Health Epidemiol 2016; 5 (4) :235-244
URL: http://johe.rums.ac.ir/article-1-212-en.html

Related article in
Google Scholar

Similar articles

A survey measuring participation and autonomy of Iranian stroke patients referring a university hospital, 2017

The prevalence of depression and related factors in diabetic patients referred to Rafsanjan diabetes center, Iran, 2016

A study of people who attempted suicide referred to the emergency ward of Ali Ibn Abi Taleb hospital, Rafsanjan, Iran (2016)

Making a more comprehensive Persian version of the Impact on Participation and Autonomy (IPA-p) scale; The Perspectives of Experts and MS patients

The Validity and Reliability of the Persian Version of the Impact on Participation and Autonomy (IPA-p) Scale in Patients with Positive Angiography

Assessment of serum chemerin level in an Iranian population with metabolic syndrome and healthy individuals in 2016

Original Article

Measuring the Level of Participation and Autonomy among people with Type II diabetes, Rafsanjan, Iran (2016)

R Vazirinejad¹

, M Rezaeian²

, F Nazari³

, SM Hosseini ^*

⁴

1- Dept. of Social Medicine, Social Determinants of Health Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
2- Dept. of Epidemiology and Biostatistics, Occupational Environmental Research Center, Medical School, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
3- Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
4- Social Determinants of Health Research Center Rafsanjan University of Medical Sciences, Rafsanjan, Iran. , mhosseini622@gmail.com

Article history

Received: 2016/12/12
Accepted: 2017/02/12
ePublished: 2017/05/30

Subject: Epidemiology

Abstract: (7671 Views)

Background: A disease impacts patients’ participation level in their individual and social life through impacting their physical and mental performance. Due to the increasing prevalence of diabetes mellitus (DM), and the importance of patients’ participation and quality of life (QOL) and the determination of the most important aspects affected by the disease in the participation and Quality of Life of patients with type II DM in Rafsanjan, Iran, the present study was conducted.

Materials and Methods: In this cross-sectional study, 227 patients with type II DM were assessed. The data collection tool consisted of a 2-part questionnaire. The first part was a demographic characteristics checklist. The second part was the Persian version of the Impact on Participation and Autonomy (IPA-p) scale. The IPA-p scale was used to collect data on the subjects' participation in their own life. Then, a trained individual completed the demographic checklist through interviews. Subsequently, the subjects were asked to complete the IPA-p scale.The collected data were analyzed in SPSS software. Statistical tests such as t-test and ANOVA were used to compare the obtained means.

Results: The highest level of participation was observed in the age group of 30-49 years, and participation was higher in men, single individuals, and individuals with a good economic status.

Conclusions: The results of the present study suggested the presence of a statistically significant relationship between the participation of patients with type II DM and individual, social, economic factors. Thus, this disease causes a reduction in their participation in different life aspects, and therefore, causes a reduction in QOL. With the consideration of the long-term course of the disease, taking measures to improve individuals’ participation level seems necessary.

Keywords: Participation [MeSH], Quality of Life [MeSH], Type 2 Diabetes [MeSH]

Full-Text [PDF 287 kb] (1149 Downloads) | | Full-Text (HTML) (1108 Views)

References

1. Badely EM, Thompson RP, Wood PH. The prevalence and severity of major disabiling conditions-- a reappraisal of the government social survey on the handicapped and impaired in Great Britain. Int J Epidemiol 1978; 7(2):145-51. [PubMed]

2. Myrray CJ, Lopez AD. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global burden of disease study. Lancet 1997; 349(9062):1347-52. [PubMed]

3. Barer D, Nouri F. Measurment of activities of daily living. Clinical Rehabilitation 1989; 3(3):179-87. [Article]

4. Skerington S, Mac Arthur P, Sumerset M. Developing item for the WHO QOL: An investigation of contemporary beliefs about quality of life related to health in Britain. Br J Health Psychol 1997; 2(1):55-72. [Article]

5. World Health Organization. Draft; Programme on mental health. WHOQOL User Manual. Division of Mental Health and Prevention of Substance Abuse. Switzerland, Geneve: World Health Organization; 1998. Report No.:WHO/MNH/MHP/98.4.Rev.1 Available from: [Report]

6. Solari A, Filippini G, Mendozzi L, Ghezzi A, Cifani S, Barbieri E, et al. Validation of Italian multipe sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry 1999; 67(2):158-62. [PubMed]

7. Murrell RC, Kenealy PM, Graham Beaumont J, Lintern TC. Assessing quality of life in persons with severe neurological disability associated with multiple sclerosis: the psychometric evaluation of two quality of life measures. Br J Health Psychol 1999; 4(4):349-62. [Article]

8. Vazirinejad R. A commiunity-based survey of quality of life and participation among people with multiple sclerosis [PhD thesis]. Nattingham: University of Nattingham; 2003. [Thesis]

9. Cardol M, de Haan RJ, van den Bos GA, de Jong BA, de Groot IJ. The development of a handicap assessment questionnaire: the impact on participation and autonomy (IPA). Clin Rehabil 1999; 13(5):411-9. [PubMed]

10. World Health Organization. ICIDH-2: Internatinal of classification of functioning and disability, Beta-2 Draft. Assessment, Classification and Epidemiology Group. Switzerland, Geneve: World Health Organization; 1999. Report No.:WHO/HSC/ACE/99.1. [Report]

11. DarvishPoor kakhki A, Abed Saeedi Z, Yaghmaie F, Alavi Majd H, Montazeri A. Survey correlation between quality of life and disease and demographic variables of diabetic patients referred to Tehran hospitals in 2004. Iranian Journal of Endocrinology and Metabolism 2006; 8(1):49-56. [Article]

12. Bagheri H, Ebrahimi H, Taghavi N, Hassani MR. Evaluation of quality of life in patients with diabetes mellitus, based on its complications, referred to Imam Hossein Hospital, Shahrood. Journal of Shahrekord University of Medical Sciences 2005; 7(2):50-6. [Article]

13. Aguiree F, Brown A, Cho NH, Dahlquist G, Dodd Sh, Dunning T, et al. IDF Diabetes Atlas. 6th ed. Basel, Switzerland: International Diabetes Federation; 2013. [Article]

14. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care 2016; 39 (Supplement 1):S13-22. [Article]

15. EI Achhab Y, Nejjari C, Chikri M, Lyoussi B. Disease-specific health related quality of life instruments among adults diabetic: a systematic review. Diabetes Res Clin Pract 2008; 80(2):171-84. [PubMed]

16. Kerten P, Sibley A, Ward CD, White B, George SL. The validity and reliability of the impact on participation and autonomy questionnaire. Clinical Rehabil 2005; 19(5):572-8. [Article]

17. Vazirinejad R, Joorian J, Taghavi MM, Lilley JM, Sayadi Anari AR. The persian version of a participation scale; Is it valid and reliable enough for use among Iranian patient with multiple sclerosis? J Clin Neurol 2015; 11(2):157-63. [PubMed]

18. Harririan H, Moghadasian S, Aghajanloo A. Quality of life and its dimensions in diabetic patients referred to the Diabete Center of Tabriz University of Medical Sciences in 2008. Iranian Journal of Diabetes & Metabolism 2008; 9(2):152-60. [Article]

19. Issa BA, Baiyewu O. Quality of life of patient with diabetes mellitus in a Nigerian teaching hospital. Hong Kong Journal of Psychiatric 2000; 16(1):27-33. [Article]

20. Baghianimoghadam MH, Afkhami Ardakani M, Mazloomi SS, Saeedzadeh M. Quality of life in diabetes type II patients in Yazd. Journal of Shahid Sadoughi University of Medical Sciences and Health Services 2007; 14(4):49-54. [Article]

21. Timareh M, Rahimi M, Abbasi P, Rezaei M, Hyadarpoor S. Quality of life in diabetic patients referred to the diabete research center in Kermanshah. Journal of Kermanshah University of Medical Sciences 2012; 16(1):63-9. [Article]

22. Sadeghi Ahari S, Arshi S, Iranparvar M, Amani F, Siahpoosh H. The effect of complictions of typeII diabetes on patientes quality of life. Journal of Ardabil University of Medical Sciences 2009; 8(4):394-402. [Article]

23. Senez B, Felicioli P, Moreau A, Le Goaziou MF. Quality of life assessment of type 2 diabetic patientes in general medicine. Presse Med 2004; 33(3):161-6. [PubMed]

24. Saadatjoo SA, Rezvanee MR, Tabyee Sh, Oudi D. Life quality comparison in type 2 diabetic patientes and none diabrtic persons. Modern Care Journal 2012; 9(1):24-31. [Article]